Mary Spellman

Mary C.
Spellman currently works at Women's Dermatologic Society, as Director, Phio Pharmaceuticals Corp., as Medical Director, American Academy of Dermatology, as Member-Editorial Board, and Panclarity LLC, as President.
Dr. Spellman also formerly worked at Biogen, Inc., as Senior Medical Director, IDEC Pharmaceuticals Corp., as Senior Director-Medical Research, the University of California San Diego, as Director-Clinical Research, Novartis Pharmaceuticals Corp., as Medical Director, TG Therapeutics, Inc., as Head-Dermatology & Drug Development, Connetics Corp., as Vice President-Clinical Research, Revance Therapeutics, Inc., as Chief Medical Officer & Senior VP-Development, Menlo Therapeutics, Inc., as Chief Medical Officer from 2018 to 2019, and Castle Creek Biosciences, Inc., as Chief Medical Officer.
Dr. Spellman received her undergraduate degree from Loyola University of Chicago and doctorate degree from The Medical College of Wisconsin, Inc.